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the proliferative capacity, which is likely mediated by PKC andGlycated albumin stimulates TGF-b1 production and protein
partly by TGF-b, glycated albumin impedes the ability of thekinase C activity in glomerular endothelial cells.
glomerular capillary endothelium to act as a first line of defenseBackground. The activation of protein kinase C (PKC) and
against deleterious circulating factors in the diabetic state.transforming growth factor-b (TGF-b) in glomerular mesangial
cells has been linked to mesangial matrix expansion in diabetic
nephropathy. The role of these mediators in affecting the
changes associated with diabetes in the biology of glomerular The glomerular lesions in diabetic nephropathy areendothelial cells (GEnCs), which synthesize components of the
characterized by mesangial extracellular matrix (ECM)glomerular basement membrane, is not known. We postulated
accumulation in association with loss of filtration areathat the PKC and TGF-b systems promote the increased endo-
thelial cell synthesis of glomerular basement membrane that and thickening of the peripheral glomerular basement
is evoked by Amadori-modified glycated albumin, which is pres- membrane [1–3]. Expansion of the mesangial matrix is
ent in elevated concentrations in diabetes. a central early feature [4], and because mesangial cellsMethods. We examined the effects of PKC inhibition on col-
can be readily established in culture, many studies havelagen IV and TGF-b1 production by mouse GEnCs incubated
focused on mesangial cell proliferative and biosyntheticwith glycated albumin and the influence of glycated albumin
on PKC activity, TGF-b1 production, and proliferation by responses to media manipulations to investigate poten-
these cells. tial diabetes-related nephropathic factors [5–11]. For ex-
Results. In physiologic (5.5 mmol/L) glucose concentrations, ample, high glucose media concentrations have been
glycated albumin caused an increase in type IV collagen pro-
shown to cause inhibition of growth, bioactivation of trans-duction that was totally prevented by a general PKC inhibitor
forming growth factor-b1 (TGF-b1), and increased ex-GF 109203X (GFX), but only partly prevented by a neutralizing
anti–TGF-b antibody. Glycated albumin increased the steady- pression of ECM proteins in mesangial cells [5, 7, 9–11].
state level of TGF-b1 mRNA and stimulated the production of Albumin modified by Amadori glucose adducts, the prin-
TGF-b1 protein, which was also prevented by the PKC inhibitor cipal circulating glycated protein, has analogous influ-
GFX. Of note, glycated albumin significantly stimulated PKC
ences on mesangial cell biology and has been shown toactivity, as measured by the phosphorylation of a PKC-specific
decrease proliferative capacity and induce coordinatedsubstrate. Cell proliferation, measured by [3H]-thymidine in-
increases in the expression of TGF-b1, the TGF-b type IIcorporation and cell counting, was decreased in the presence
of glycated albumin. This effect was completely prevented by receptor, type IV collagen, and fibronectin [12–16].
GFX and partially reversed by anti–TGF-b antibody. Exoge- Less well studied, perhaps because they have been
nous TGF-b1 inhibited cell proliferation to a degree similar difficult to isolate and propagate in culture, are glomeru-to that of glycated albumin.
lar endothelial cells (GEnCs) [17–19]. Glucose and gly-Conclusions. PKC signaling and consequent TGF-b1 activa-
cated albumin have been shown to adversely affect thetion participate in the glycated albumin-induced stimulation of
basement membrane collagen production by GEnC. By reducing biology of endothelial cells cultured from large blood
vessels and umbilical veins [20–24]. In endothelial cells
from large vessels, for example, glycated albumin stimu-
1 See Editorial by Striker, p. 799. lates nitric oxide synthase activity and gene expression
[25]. However, endothelial cells from capillary beds suchKey words: Amadori, nonenzymatic glycation, basement membrane,
type IV collagen, cell proliferation, diabetic nephropathy. as the glomerular tuft may behave differently in response
to pathobiologic factors [18, 26–28]. Relatively little isReceived for publication January 20, 2000
known about factors that modulate the biology ofand in revised form August 2, 2000
Accepted for publication September 5, 2000 GEnCs, which produce a portion of the peripheral glo-
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about influences in these cells that are relevant to the and fulfills criteria for endothelial cells as previously
pathogenesis of diabetic nephropathy. Compared with described [49]. The cells stain positive for factor VIII
mesangial cells, GEnCs express more a3(IV) collagen and CD31, express angiotensin-converting enzyme, and
mRNA [30], and they respond to a high glucose media release endothelin-1 in response to angiotensin II [49].
concentration with increased synthesis of type IV colla- We have also demonstrated that GEnCs express the
gen [19]. We have shown that glycated albumin, in con- novel a3 and a5 chains of collagen IV, which are compo-
centrations found in clinical specimens, stimulates the nents of the glomerular basement membrane (data not
production of type IV collagen and fibronectin in a glo- shown). Cells were maintained at 378C in a humidified
merular endothelial cell line, even in the absence of high incubator with 5% CO2/95% air and were propagated in
ambient glucose [31]. However, the molecular mediators Dulbecco’s modified Eagle’s medium (DMEM; GIBCO
underlying the increased matrix production by glycated BRL, Grand Island, NY, USA) containing 10% fetal
albumin in these cells have not been elucidated. Since calf serum (FCS), 100 U/mL penicillin, 100 mg/mL strep-
glycated albumin in increased concentrations bathes the tomycin, and 2 mmol/L glutamine. Cells were passaged
glomerular vascular bed in diabetes [16], the mechanisms every four to five days by light trypsinization. To initiate
by which the glycated protein modulates glomerular en- experiments under varying culture conditions, cells were
dothelial biology warrant investigation.
seeded into 96-well (thymidine incorporation and cellBecause the effects of glycated albumin on ECM pro-
counting) or 24-well (collagen IV, TGF-b1, and PKCduction in GEnC resemble those observed in mesangial
assays) plastic plates or into 100 mm Petri dishes (RNAcells, we postulated that the cytokines and signaling fac-
analysis), grown for 24 to 48 hours in media containingtors mediating increased matrix synthesis might be com-
10 mmol/L glucose and 2% FCS, and then incubated formon to both cell types. In mesangial cells, stimulation
24 to 72 hours in fresh media under the experimentalof type IV collagen, laminin, and fibronectin expression
conditions described later in this article.are associated with increased expression of the fibrogenic
cytokine TGF-b1 [11, 14] and activation of the signal
Experimental conditionstransduction factor protein kinase C (PKC) [32–36].
The experimental culture conditions were introducedOther evidence linking the TGF-b system and PKC acti-
upon the addition of fresh media containing 5.5, 10 (thy-vation to altered glomerular cell biology in diabetes in-
midine incorporation and cell counting), or 25 (TGF-b1cludes studies in experimental animal models showing
assay) mmol/L glucose and 2 or 10% (RNA analysis)that renal TGF-b1 expression and PKC activity are in-
FCS, without or with the described supplements in thecreased, that renal overexpression of matrix proteins can
be lessened by treatment with anti–TGF-b antibody, and indicated concentrations. Media supplements consisted
that glomerular hyperfiltration and albuminuria can be of purified glycated or nonglycated albumin (500 mg/mL),
ameliorated by inhibiting the PKC-b isoform [34, 37–45]. prepared as described later in this article, the PKC inhibi-
These considerations prompted the present experi- tor GFX (500 nmol/L; Calbiochem, La Jolla, CA, USA),
ments, which attempt to determine whether glycated TGF-b1 (1 ng/mL; R&D Systems, Minneapolis, MN,
albumin modulates PKC activity in GenC, and whether USA), and a pan-selective neutralizing monoclonal anti–
activation of PKC and increases in TGF-b1 are involved TGF-b antibody (30 mg/mL; gift of Dr. Brian M. Fendly
in the stimulated ECM expression that occurs when of Genentech, South San Francisco, CA, USA) [37] or
GEnCs are incubated with glycated albumin [31]. The an irrelevant murine IgG (30 mg/mL).
compound GF 109203X (GFX) was used to inhibit the
various PKC isoforms, and a pan-selective monoclonal Albumin preparation
antibody was used to neutralize TGF-b. Since high ambi- Glycated albumin was prepared by separation of hu-
ent glucose concentrations have been reported to acti- man serum albumin with chromatography on Affi-gel
vate PKC and to augment the expression of TGF-b1 and blue and DEAE-Sepharose, followed by incubation for
ECM proteins [11, 32, 35, 36, 46–48], all incubations five days at 258C in buffered saline containing 28 mmol/L
were conducted in 5.5 to 10 mmol/L glucose media (ex-
glucose. After dialysis to remove free glucose, the gly-cept where specifically indicated) to ensure that observed
cated species were separated from nonglycated albuminresponses did not accrue from an independent effect of
by affinity chromatography on phenylboronate agaroseelevated glucose. Parallel incubations with nonglycated
(PBA), which binds the Amadori glucose adducts. Thisalbumin, in the same concentration as glycated albumin,
procedure has been shown to yield glycated albuminserved as controls.
containing 1 to 2 mol glucose/mol albumin, and glycated
moieties are represented as deoxyfructosyllysine [13, 50].
METHODS The PBA pass-through, which was used as source mate-
Cell culture rial for nonglycated albumin, contained ,0.05 mol glu-
cose/mol albumin. The purified glycated and nonglycatedAll studies were performed on a murine glomerular
endothelial cell line that is spontaneously immortalized albumin preparations migrated on sodium dodecyl sul-
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fate-polyacrylamide gel electrophoresis (SDS-PAGE) as (EHS) tumor as the standard, rabbit anti-mouse type IV
homogeneous bands of approximately 66 kD and had collagen as the primary antibody (both from Collabora-
distinct mobilities on agarose gel electrophoresis, wherein tive Research, Medford, MA, USA), and horseradish
the glycated protein exhibited greater electronegativity peroxidase-conjugated goat anti-rabbit IgG (Bio-Rad,
consequent to glycation of lysine amino groups [50]. The Hercules, CA, USA) as secondary antibody. The assay
concentration of glycated albumin used in these experi- was performed on media collected at the end of the
ments has been shown to modulate mesangial cell biol- experimental incubation period and on cell contents after
ogy and is in the range of concentrations found in diabetic lysis according to the previously mentioned procedure.
specimens [13, 14]. In GEnCs, the cell-associated collagen IV fraction was
substantial, and therefore, media and cell lysate mea-
Cell proliferation surements for each incubation were summed and nor-
The [3H]-thymidine incorporation assay was per- malized to total protein measured with the Bio-Rad pro-
formed in 96-well microtiter plates in 200 mL total vol- tein assay. Pilot studies have shown that both fractions
ume. At the end of a 48-hour incubation period, the cells are stimulated proportionately by glycated albumin.
were pulsed for four hours with [3H]-thymidine (1 mCi/
well, 5 to 7 Ci/mmol; Amersham, Arlington Heights, IL, TGF-b1 measurement
USA). After trypsinization, cells were collected onto Transforming growth factor-b1 levels in spent media
glass microfiber filters (Whatman, Maidstone, UK) using collected at the end of the experimental period were
a cell harvester, and radioactivity was assayed by placing measured by immunoassay (Genzyme, Cambridge, MA,
the filters in a liquid scintillation fluid (ICN) and counting USA). Samples were acidified to separate the latency-
the [3H] decay in a liquid scintillation counter [10, 51]. associated peptide from the TGF-b1 dimer, allowing
Proliferation of cells grown in 96-well microtiter plates measurement of total TGF-b1 (active plus latent compo-
was also determined by direct cell counting. After 72 nents) and then neutralized with NaOH [38, 52]. Ac-
hours of growth, GEnCs were subjected to three minutes cording to the vendor, the primary antibody issued in
of trypsinization followed by resuspension in fresh media this assay has negligible cross-reactivity with TGF-b2
supplemented with 10% FCS to neutralize the trypsin. and TGF-b3.
An inverted microscope was used to count the cells in
a Bright Line Counting Chamber (Hausser Scientific, RNA hybridization analysis
Horsham, PA, USA).
RNA was extracted from endothelial cells after cul-
ture under the described conditions and hybridized withPKC activity
[32P]-labeled cDNA probe as previously described [12, 14].Protein kinase C activity was measured with the Pep
Briefly, cells were denatured in TRIzol reagent (GIBCOTag assay system (Promega, Madison, WI, USA), in which
BRL), and RNA was purified according to the manufac-the change in charge of a fluorescent-tagged PKC-specific
turer’s instructions. Twenty micrograms of total RNA weresubstrate PLSRTLSVAAK that occurs with phosphoryla-
electrophoresed on a 1.2% agarose gel, transferred ontotion is detected upon separation with agarose gel electro-
nylon membranes, and ultraviolet wave cross-linked. In-phoresis at neutral pH. At the end of the incubation, the
tegrity and equal loading of samples were assessed bycells were washed with Hank’s balanced salt solution con-
methylene blue staining of the transferred RNA. Aftertaining 1 mmol/L phenylmethylsulfonyl fluoride (PMSF)
hybridization with the TGF-b1 cDNA probe, blots wereand 1 mmol/L leupeptin, placed in 100 mL of the same buf-
successively washed in 2 3 standard saline citrate (SSC)fer, and then freeze thawed for lysis. Aliquots were taken
at room temperature, 2 3 SSC/1% SDS at 628C, andfor the assay, which was performed according to the man-
0.1 3 SSC/0.1% SDS at 628C. The membranes wereufacturer’s instructions. Photographs of the gels were
autoradiographed with intensifying screens at 2708C forscanned into a densitometer program (Scion Image; Na-
up to three days. Blots were then stripped for two hourstional Institutes of Health, Bethesda, MD, USA) for
at 628C with 5 mmol/L Tris, 0.2 mmol/L ethylenedi-quantitation. Each assay included a positive control for
aminetetraacetic acid (EDTA; pH 8.0), and 5% sodiumPKC activity wherein PKC supplied by the manufacturer
pyrophosphate and subsequently rehybridized with thewas simultaneously subjected to the assay and electro-
mrpL32 cDNA probe to account for small variations inphoretic procedure. A negative control was also run with
RNA loading and transfer. Exposed films were scannedeach assay.
into a densitometer program (Scion Image; National
Type IV collagen measurement Institutes of Health) for quantitation of TGF-b1 mRNA,
which was later corrected for the relative amount ofType IV collagen was measured by competitive en-
mrpL32 mRNA. Preparation of the cDNA probe encod-zyme-linked immunosorbent assay (ELISA) [12, 13] us-
ing type IV collagen from an Engelbreth-Holm-Swarm ing TGF-b1 was as previously described [38].
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Fig. 1. Effect of glycated albumin and protein kinase C (PKC) inhibi-
tion on collagen IV production. Glomerular endothelial cells (GEnCs)
were cultured for 48 hours in DMEM containing 5.5 mmol/L glucose/2%
FCS and no supplement (media), nonglycated albumin (NA), or gly-
cated albumin (GA) at 500 mg/mL, without (h) or with (j) 500 nmol/L
of the PKC inhibitor GF 109203X (GFX). From each condition, media
and cell lysates were collected for immunoassay of collagen IV as
described in the text. Results represent the mean 6 SEM of four
independent cultures and are expressed as micrograms of collagen IV
normalized to milligrams of protein. *P , 0.05 compared with nongly-
cated albumin; #P , 0.05 compared with glycated albumin, no GFX.
RESULTS
Collagen IV production
Incubation with glycated albumin in 5.5 mmol/L glu-
cose significantly stimulated collagen IV production,
whereas incubation with nonglycated albumin had no Fig. 2. Protein kinase C (PKC) activity in glomerular endothelial cells
(GEnCs). GEnCs were cultured for 48 hours in DMEM containingeffect relative to control (Fig. 1). This stimulation by
5.5 mmol/L glucose/2% FCS and no supplement (media), nonglycatedglycated albumin was prevented in the presence of GFX, albumin (NA), or glycated albumin (GA) at 500 mg/mL, without or
a general inhibitor of PKC isoforms (Fig. 1). with 500 nmol/L of the PKC inhibitor GF 109203X (GFX). In each
lane of the gel, nonphosphorylated substrate is shown on the left andA neutralizing anti-TGF-b antibody was used to deter-
phosphorylated substrate on the right. Negative control (lane A) showsmine whether activation of endogenous TGF-b mediated no phosphorylated substrate. Positive control (lane B), obtained with
the stimulation of collagen IV production. In the pres- PKC supplied by Promega, shows abundant phosphorylated substrate.
Lane C 5 media; lane D 5 media 1 GFX; lane E 5 nonglycatedence of glycated albumin (500 mg/mL for 48 h), immuno-
albumin; lane F 5 nonglycated albumin 1 GFX; lane G 5 glycatedreactive collagen IV levels were increased by 88 6 10% albumin; lane H 5 glycated albumin 1 GFX.
above control (N 5 4, P , 0.05). Concurrent anti–TGF-b
antibody treatment (30 mg/mL) of cells incubated in gly-
cated albumin reduced the collagen IV protein level by which cells were incubated for 48 hours in 5.5 mmol/L
47 6 4% (N 5 4, P , 0.05), suggesting that TGF-b glucose indicated that PKC activity was increased in cells
was partly responsible for the glycated albumin-induced cultured in media containing glycated albumin compared
collagen IV production. It should be noted that supple- with nonglycated albumin in the same concentration
mentation of cultures with 1 ng/mL TGF-b1 in the ab- (Fig. 2). Densitometric scanning of the gel photographs
sence of glycated albumin provided only a modest stimu- confirmed that exposure to glycated albumin significantly
lation (37 6 7%) of collagen IV synthesis by GEnC (N 5 stimulated PKC activity in 5.5 mmol/L glucose media
4, P , 0.05). (Fig. 3). This stimulation was prevented by the PKC
inhibitor GFX (Figs. 2 and 3).
Protein kinase C activity
TGF-b1 productionThe ability of glycated albumin to increase PKC activ-
ity was assessed in the substrate-specific phosphorylation To determine whether changes in TGF-b1 production
accompanied the increases in collagen IV synthesis andassay. Visual inspection of gels from experiments in
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Fig. 3. Effect of glycated albumin and PKC inhibition on PKC activity.
GEnCs were cultured and analyzed for PKC activity as described in the
legend to Figure 2 and in the text. Data were obtained by densitometric Fig. 4. TGF-b1 production in GEnCs. GEnCs were cultured for 48
scanning of photographs of gels. Results represent the mean 6 SEM hours in DMEM containing 5.5 mmol/L glucose (A) or 25 mmol/L
of four independent cultures and are expressed as the relative ratio of glucose (B) and nonglycated albumin (NA) or glycated albumin (GA)
the densitometry of phosphorylated substrate in control cells (media, no at 500 mg/mL, without (h) or with (j) 500 nmol/L of the PKC inhibitor
GFX), arbitrarily assigned a value of 1. *P , 0.05 compared with non- GF 109203X (GFX). From each condition, media were collected for
glycated albumin; #P , 0.05 compared with glycated albumin, no GFX. immunoassay of TGF-b1 as described in the text. Results represent the
mean 6 SEM of four to six independent cultures and are expressed as
ng TGF-b1 normalized to cell number. *P , 0.05 compared with the
respective nonglycated albumin; #P , 0.05 compared with the respective
glycated albumin, no GFX; † P , 0.05 compared with the respective
PKC activity observed with glycated albumin, concentra- nonglycated albumin, no GFX.
tions of the translated TGF-b1 protein were measured by
ELISA in spent media. TGF-b1 was significantly greater
in the supernatants from cells incubated with glycated in cells incubated with glycated albumin compared with
nonglycated albumin (Fig. 5).albumin compared with nonglycated albumin (Fig. 4).
This increase was prevented by the PKC inhibitor GFX
Cell proliferation(Fig. 4). For comparative purposes and because the effect
Experiments to assess the effect of glycated albumin onof elevated media glucose on TGF-b1 production by
the proliferation of GEnC were conducted in 10 mmol/LGEnCs has not been previously examined, additional
glucose, using [3H]-thymidine incorporation and cell countsexperiments were performed with media containing 25
as measures of replication. Compared with incubationsmmol/L glucose and nonglycated versus glycated albu-
in media alone or media supplemented with nonglycated
min. In the presence of nonglycated albumin, TGF-b1 albumin, incubations in media with glycated albumin sig-
concentrations were significantly higher in spent media nificantly inhibited [3H]-thymidine incorporation (Fig. 6)
from incubations in high glucose than in normal glucose and reduced cell number (Fig. 7). Moreover, the decrease
(Fig. 4, B vs. A), and this increase was significantly atten- in [3H]-thymidine incorporation associated with exposure
uated by the PKC inhibitor GFX. TGF-b1 production to glycated albumin was prevented when the PKC inhibi-
was further augmented when cells were incubated in the tor GFX was added to the incubation (Fig. 6A). The ad-
combination of glycated albumin and 25 mmol/L glucose, dition of anti–TGF-b antibody dampened the inhibition
consistent with an additive effect (Fig. 4B). When GFX of proliferation caused by glycated albumin (Fig. 6B),
an effect that was almost statistically significant (N 5 5,was added to incubations containing glycated albumin
P 5 0.06 vs. glycated albumin alone). Consistent within 25 mmol/L glucose media, TGF-b1 concentrations
the known antiproliferative effect of TGF-b in GEnCswere reduced to those of incubations containing nongly-
[53], the addition of exogenous TGF-b1 (1 ng/mL) causedcated albumin in 25 mmol/L glucose media (Fig. 4B).
significant inhibition of [3H]-thymidine incorporationCorroboration that glycated albumin stimulated the
(Fig. 6B) and reduction of cell number (Fig. 7).TGF-b system in GEnC was obtained with hybridization
analysis for mRNA encoding TGF-b1. Northern blot
DISCUSSIONanalysis showed that the steady-state level of TGF-b1
mRNA (factored for the housekeeping gene mrpL32) In these studies, we adhered to conditions in which the
glycated protein was represented by albumin modified bywas increased by an average of 30% (N 5 4, P , 0.001)
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Fig. 6. Effect of glycated albumin and TGF-b modulation on [3H]-thy-
midine incorporation. GEnCs were cultured for 48 hours in DMEM
containing 10 mmol/L glucose/2% FCS and no supplement (Media),
nonglycated albumin (NA), or glycated albumin (GA) at 500 mg/mL.
(A) Cells were incubated without (h) or with (j) 500 nmol/L of theFig. 5. TGF-b1 gene expression in GEnCs. GEnCs were cultured for
PKC inhibitor GF 109203X (GFX). (B) Cells were incubated without48 hours in DMEM containing 5.5 mmol/L glucose/10% FCS and non-
other addition (h) or with 1 ng/mL TGF-b1 (T, ), 30 mg/mL irrelevantglycated albumin (NA) or glycated albumin (GA) at 500 mg/mL. Data
murine IgG (IgG, j), or 30 mg/mL neutralizing anti-TGF-b antibodywere obtained by densitometric scanning of autoradiographs of North-
(aT, ). From each condition, cells were collected for scintillationern blots successively probed with TGF-b1 and mrpL32 cDNA. A
counting of [3H]-thymidine incorporation as described in the text. Re-representative autoradiograph is shown on top. Results represent the
sults represent the mean 6 SEM of five independent cultures and aremean 6 SEM of four independent cultures and are expressed as the
expressed as counts per minute (cpm) of [3H] decay. *P , 0.05 comparedpercentage of the densitometric ratio of TGF-b1 to mrpL32 mRNA in
with the respective Media or nonglycated albumin; #P , 0.05 comparedcontrol cells (NA), arbitrarily assigned a value of 100. *P , 0.05 com-
with the respective glycated albumin, no GFX.pared with nonglycated albumin.
tor GFX totally prevented the glycated albumin-induced
Amadori glucose adducts and not by advanced glycation increases in translated TGF-b1 and type IV collagen pro-
end-products (AGE), because the former is the principal teins. The existence of a PKC-responsive activated pro-
physiologic construct in which glycated albumin exists in tein-1 (AP-1) site in the promoter of the TGF-b1 gene
vivo. Previous work has shown that the Amadori-modified provides a plausible molecular basis for PKC signaling
protein can influence functional properties of mesangial of TGF-b1 production [56, 57].
and endothelial cells in vitro and in vivo [12, 14, 16, 25, Although glycated albumin-induced PKC activation
36, 54, 55]. may also stimulate collagen IV gene transcription through
In GEnCs, we found that PKC signaling predomi- direct AP-1 binding, the involvement of the profibrotic
nantly mediated the increased synthesis of TGF-b1 and cytokine TGF-b as an intermediary between these events
collagen IV in response to glycated albumin. This inter- should be considered. We found, however, that a neutral-
pretation was based on the findings that glycated albumin izing antibody against TGF-b did not fully prevent the
increased collagen IV synthesis in response to PKC acti-could activate the PKC system and that the PKC inhibi-
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and that high glucose and TGF-b1 exert their effects
through distinct pathways and at different loci.
Our findings and those of others [18, 26–28] suggest
that endothelial cells of glomerular origin respond to
potential modulating factors in ways that are both similar
to and different from the behavior of endothelial cells of
larger vessels such as the aorta or umbilical vein. Both
cell types, for example, show decreased proliferation with
addition of TGF-b1 or glycated albumin [24, 58]. In con-
trast to the situation with umbilical vein endothelial cells,
however, high glucose and glycated albumin significantly
stimulated TGF-b1 production by GEnC. Antagonism of
endogenous TGF-b with a neutralizing antibody partly
restored the proliferative capacity of the cells in glycated
Fig. 7. Effect of glycated albumin and TGF-b1 on cell counts. GEnCs albumin (P 5 0.06), but perhaps more complete inhibi-were cultured for 48 hours in DMEM containing 10 mmol/L glucose/2%
tion of TGF-b could have normalized GEnC prolifera-FCS and no supplement (Media), nonglycated albumin (NA), or gly-
cated albumin (GA) at 500 mg/mL, without (h) or with ( ) 1 ng/mL tion. This possibility is supported by the finding that the
TGF-b1. From each condition, cells were collected for cell counting PKC inhibitor GFX, which almost normalized TGF-b1as described in the text. Results represent the mean 6 SEM of five
production in cells incubated with glycated albumin, alsoindependent cultures and are expressed as the number of cells per well.
*P , 0.05 compared with Media, no TGF-b1; #P , 0.05 compared with successfully reversed the inhibition of [3H]-thymidine in-
nonglycated albumin. corporation caused by glycated albumin. Our data indi-
cate that glycated albumin exerts at least some of its anti-
proliferative action through induction of TGF-b, but this
does not exclude the involvement of other PKC-acti-vation, and exogenous TGF-b1 only modestly stimulated
collagen IV production in the absence of glycated albu- vated factors.
The glomerular capillary endothelium is strategicallymin. Others have also reported that the addition of
TGF-b1 to cultured GEnCs did not significantly stimu- positioned between the circulation and other glomerular
elements, and it forms the first line of defense againstlate collagen IV expression [30]. Nevertheless, our data
suggest that PKC-signaled endogenous TGF-b bioactiv- deleterious metabolic, biochemical, and hemodynamic
factors presented to the kidney. In the diabetic state,ity mediated some stimulation of collagen IV synthesis
in response to glycated albumin. In this respect, our influences such as hyperglycemia and elevated glycated
serum protein levels trigger maladaptive biosynthetic pro-findings with GEnCs are analogous to those with mesan-
gial cells in which the glycated albumin-induced increase grams that contribute to pathobiologic processes [20–24].
High glucose, for instance, increases the expression ofin TGF-b1 has been linked to PKC activation and in-
creased ECM protein synthesis [14, 36]. This interpreta- basement membrane components in large vessel endo-
thelial cells [20] and stimulates the production of TGF-b1tion is consistent with reports that TGF-b1 up-regulates
fibronectin expression in umbilical vein endothelial cells in GEnCs. Glycated albumin, as seen in this study, in-
creases PKC activity, TGF-b1 levels, and ECM expres-[58] and that glycated albumin stimulates fibronectin
production in GEnCs [31]. Additional experiments are sion in GEnCs, but it does not require high ambient
glucose to achieve these effects. Finally, glycated albu-necessary to define the role of TGF-b isoforms and their
receptors in glomerular capillary basement membrane min stimulates TGF-b1 and ECM protein production in
mesangial cells incubated with normal glucose media,and fibronectin synthesis and to identify other potential
mediators of matrix production in GEnCs. further documenting that glycated albumin exerts its own
potent biologic effects [12, 14, 15, 36].In a study of human umbilical vein endothelial cells,
Cagliero et al found that high glucose did not augment In general, we have found that mesangial cells respond
more vigorously to glycated albumin than GEnCs. InTGF-b production, measured by bioassay as total TGF-b,
but both high glucose and exogenous TGF-b1 did inhibit similar experiments with comparable levels of glycated
albumin, mesangial cells raised their TGF-b1 mRNAcell replication [58]. The growth-inhibitory effect of high
glucose was reversed after the cells were incubated in levels by an average of 160% above control [14] versus
30% for GEnCs in this study. Mesangial cells also in-normal glucose media, but the inhibitory effect of TGF-b1
was not reversed after cells were incubated without the creased their collagen IV production by as much as 100%
above control [36] versus 50% for GEnCs. The signifi-cytokine. The investigators concluded that high glucose
does not significantly stimulate TGF-b1 production in cance of the quantitative differences in the effects of gly-
cated albumin on the two glomerular cell types is uncer-umbilical vein endothelial cells, that the growth-inhibi-
tory effects of high glucose are independent of TGF-b1, tain. In addition, the extent to which these in vitro data
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angial cell growth and collagen gene expression. Kidney Int 45:475–in GEnC can be extrapolated to the in vivo situation
484, 1994
would need to be determined. 13. Ziyadeh FN, Cohen MP: Effects of glycated albumin on mesangial
The observation that glycated albumin, independent cells: Evidence for a role in diabetic nephropathy. Mol Cell Bio-
chem 125:19–25, 1993of glycemic status, inhibits the proliferative capacity of
14. Ziyadeh FN, Han DC, Cohen JA, et al: Glycated albumin stimu-the endothelial cell barrier and promotes the production lates fibronectin gene expression in glomerular mesangial cells:
of basement membrane collagen strengthens the concept Involvement of the transforming growth factor-b system. Kidney
Int 53:631–638, 1998that glycated albumin substantively contributes to the
15. Cohen MP, Hud E, Wu VY, et al: Albumin modified by Amadoripathogenesis of glomerular lesions in diabetes. Future glucose adducts activates mesangial cell type IV collagen gene
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